A mouse metastatic breast cancer model observed that a low dose of c-di-GMP provided a potent adjuvant effect with the LM-Mb vaccine by promoting the production of IL-12 derived from MDSCs and increasing the response of CD8+ T cells to the tumor-associated antigen Mage-b. Here, CD8A is linked to breast carcinoma.